MRI scans may predict immune response in HER2+ breast cancer
NCT ID NCT03738553
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study looked at whether special MRI scans can detect early signs of immune response in women with HER2-positive breast cancer after one round of anti-HER2 treatment. Researchers enrolled 13 adults with stage I to III breast cancer who were scheduled for surgery and anti-HER2 therapy. The goal was to see if MRI changes matched immune cell levels in the tumor, but the study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seattle Cancer Care Alliance
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.